Arash Latifoltojar1, Margaret Hall-Craggs2, Alan Bainbridge2, Magdalena Sokolska2, Kwee Yong1, Neil Rabin2, Liam Watson1, Michelle Siu2, Matthew Benger2, Nikolaos Dikaios1, and Shonit Punwani1
Whole body magnetic resonance imaging is becoming the gold standard imaging in initial assessment of multiple myeloma. Recently, functional imaging is being investigated in treatment response monitoring in multiple myeloma. We investigated different functional MRI biomarkers' temporal changes at early post-treatment stage in multiple myeloma patients following Bortezomib induction.